"Two-invoice system" refers to the drugs sold from the pharmaceutical factory to the first dealer to open an invoice, the dealer sold to the hospital to open another invoice to "two votes" instead of the current common seven votes, eight votes, to reduce the circulation of layers of exploitation, and each variety of first-class Dealers shall not exceed 2. Drug circulation has been a long time, relying only on spontaneous market regulation in the short term is difficult to achieve results, we must unswervingly implement the "two-ticket system", with a tangible hand to cut off the gray chain of interests, to reduce the inflated prices of medicines. Compression of the circulation link is the direct purpose of the implementation of the "two-invoice system", mainly for the purchase and sale of drugs in the process of the existence of more links and multi-level agents and other issues, so that the intermediate increase in price transparency, so that the circulation market to be cleaned up, so that the price of drugs to return to a reasonable level. The implementation of the "two-ticket system" is in line with internationally accepted practices: after drugs become the cost of medical institutions, the circulation chain is usually compressed into a "two-ticket" model. Compared to the practice of many European and American countries of directly controlling the profit level of distribution companies, the "two-ticket system" is not considered excessive intervention. Combined with the reform of public hospitals, the "two-invoice system" can help accelerate the elimination of the mechanism of compensating doctors with medicines, establish an efficient distribution system, and quickly adjust the distorted industrial structure. From international experience, after the concentration of the drug market increases, the state can not only effectively regulate the market, the cost of regulation will also be greatly reduced.
Legal basis: "The State Council Medical Reform Office and other 8 departments issued on the implementation of the "two-invoice system" in the procurement of medicines in public medical institutions (trial) of the notice" (State Medical Reform Office issued [2016] No. 4) stipulates that the two-invoice system refers to the pharmaceutical production enterprises to the The two-invoice system means that the drug manufacturing enterprise will issue an invoice to the circulation enterprise once, and the circulation enterprise will issue an invoice to the medical institution once. The wholly-owned or controlling commercial companies (limited to one commercial company nationwide) and the domestic general agents of overseas drugs (limited to one general agent nationwide) set up by drug manufacturers or group-type enterprises integrating science, industry and trade can be regarded as manufacturing enterprises. Drug distribution group-type enterprises within the wholly-owned (controlling) subsidiaries or wholly-owned (controlling) subsidiaries between the transfer of drugs may not be regarded as a one-vote, but only allowed to invoice at most once. Drug manufacturers and distributors shall reasonably determine the level of markup in accordance with the principles of fairness, legality and good faith. Encourage public medical institutions and drug manufacturers to directly settle drug payments, drug manufacturers and distribution companies to settle distribution costs.